Showing results (111-120 of 123) with videos related to
Sort By:
Pageof 13
Anticancer Research|February 4, 2019
Use of a Reinforced Triple-row Stapler Following Distal Pancreatectomy Reduces the Incidence of Postoperative Pancreatic Fistula in Patients With a High BMIHiromichi Kawaida, Hiroshi Kono, Hidetake Amemiya, et al.Oncology Reports|January 14, 2022
Soluble podoplanin as a biomarker in diffuse‑type gastric cancerKoichi Takiguchi, Katsutoshi Shoda, Takashi Nakayama, et al.Oncology Letters|August 30, 2024
Molecular mechanisms driving the interactions between platelet and gastric cancer cells during peritoneal disseminationTakashi Nakayama, Ryo Saito, Shinji Furuya, et al.Anticancer Research|February 2, 2024
Investigating Cytoglobin Expression in Colon Cancer: Clinicopathological Insights from Immunohistochemical AnalysisTakashi Nakayama, Shinji Furuya, Yudai Higuchi, et al.Anticancer Research|April 27, 2024
Re-consideration of Lymph Node Metastasis in Pancreatic Cancer Patients Following Radical Resection: A Retrospective StudyRyo Saito, Hiromichi Kawaida, Wataru Izumo, et al.Cancer Science|August 5, 2025
Potential of Platelet-Based Drug Delivery System for Treating Peritoneal Metastasis of Gastric CancerTakashi Nakayama, Katsutoshi Shoda, Yudai Higuchi, et al.Anticancer Research|January 9, 2021
Early Drain Removal Regardless of Drain Fluid Amylase Level Might Reduce Risk of Postoperative Pancreatic FistulaHiromichi Kawaida, Hiroshi Kono, Hidetake Amemiya, et al.Oncology Letters|November 29, 2023
Inhibition of cancer cell‑platelet adhesion as a promising therapeutic target for preventing peritoneal dissemination of gastric cancerTakashi Nakayama, Ryo Saito, Shinji Furuya, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 25, 2022
[Long-Term Prognosis of Patients with Biliary Tract Cancer Undergoing Pancreaticoduodenectomy]Akihito Mizukami, Hiromichi Kawaida, Tsugihiro Hayashi, et al.Digestion|January 16, 2023
Analysis of Circulating DNA to Assess Prognoses for Metastatic Colorectal Cancer Patients Treated with Regorafenib Dose-Escalation Therapy: A Retrospective, Exploratory Analysis of the RECC TrialRyo Ohta, Takeshi Yamada, Masato Nakamura, et al.Pageof 13